We were thrilled to attend this year’s Irish Medtech #MedtechRising summit, a one-day event filled with groundbreaking discussions, expert insights, and opportunities to connect with leading minds. Jennifer McMahon , Partner at Seroba. took part in the panel discussion on "Founders to Fundraising and Partnerships" and also contributed to judging the pitching companies for Medtech Connect+. A special congratulations to the winner Judi O' Malley of Spiorad Medical Limited . It was an honour to sponsor the prize of two tickets to April's MedTech Strategist conference in Dublin.
Seroba.
Venture Capital and Private Equity Principals
Dublin , Ireland 3,630 followers
A leading European life sciences venture capital firm.
About us
Investing in life sciences. Investing in life. Seroba is a European life sciences venture capital firm based in Dublin and Paris, investing its fourth Fund. We focus on value creation through backing cutting-edge biotech and medtech innovation that will transform the treatment of unmet medical needs. Our team has deep industry and operational experience and an extensive global network. We like to work with entrepreneurs who share our passion for success and for investors who share the same goal of improving human health while driving financial returns.
- Website
-
http://www.serobavc.com
External link for Seroba.
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- Dublin , Ireland
- Type
- Partnership
- Founded
- 2002
- Specialties
- Venture Capital for Life Sciences, Investing in pharma opportunities, Investing in Biotech, Investing in Medtech, European Life Science Funding, Venture Capital, Biotech, Medical Devices, Startups, and Innovation
Locations
-
Primary
Get directions
34 Upper Mount Street
Dublin , Ireland D02 FT72, IE
Employees at Seroba.
Updates
-
Huge congratulations to the incredible Sharon Cunningham and Orlaith Ryan for being honoured with the 2024 EY Entrepreneurs of the Year award. This recognition is a testament to your commitment, vision and expertise. Through your hard work, Shorla Oncology has revolutionised oncology treatments through formulation re-innovation. We are proud to have partnered with you on this journey and look forward to celebrating more milestones together. Here's to continued success and impact!
Congratulations to Sharon Cunningham and Orlaith Ryan of Shorla Oncology on being crowned the 2024 EY Entrepreneur Of The Year! #EOYIreland2024 #ShapeTheFutureWithConfidence Thank you to our sponsors Julius Baer, Enterprise Ireland and Invest Northern Irelandand our media partners Newstalk and The Irish Times
-
Great news for ARTICA Therapeutics , a Seroba. portfolio company, with the establishment of their Scientific Advisory Board. Excited to see what the future holds with the new members to the team.
Artica Therapeutics is very pleased to formally announce the establishment of its Scientific Advisory Board (SAB). The SAB, with Jackie Benson, Andrew Mortlock, Luke O'Neill, and Jason Witherington as distinguished academic and pharma experts, will help guide our company as we advance our exciting autoimmune pipeline of covalent small molecules. The SAB will be chaired by Artica co-founder, Professor Ad IJzerman. Read more: www.artica-tx.com/news
-
-
Seroba. reposted this
Please find below the new report on Life Sciences Investment in the EU unveiled by FTI Consulting and EUCOPE - European Confederation of Pharmaceutical Entrepreneurs. https://lnkd.in/eVtMxCaC Worth a read. Seroba. with Bruno Montanari was happy to participate in this initiative from the investors perspective, and in this pivotal moment for Europe as recently stressed out by the Mario Draghi report. Some key takeaways: the EU benefits from world-class academic research and innovation, but it also faces challenges such as limited availability and access to EU capital, as well as complex market access procedures. The report also aims to draw up a series of recommendations to enhance the EU's attractiveness for LifeSciences investments and to improve access to innovative medicines in Europe. Thank you to FTI Consulting, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs and Broadreach Global. #FuellingInnovation #Europe #Biotech #Seroba
Broadreach Global was honored to once again work with the fantastic healthcare team at FTI Consulting and with EUCOPE - European Confederation of Pharmaceutical Entrepreneurs on the report "The Economic Lens: Understanding What Makes the EU Attractive for Life Sciences Investments." Please have a look to understand the investor perspective on improving access to innovative medicines in Europe while fostering rather than stifling innovation and the European biotechnology sector, in light of the proposed EU Pharmaceutical Package. SEE THE REPORT https://lnkd.in/e_SSs2H7 It was a pleasure working with Katja Murray, Victor Maertens, Stefano Romanelli, Tiago Beck, and Lars Stollenwerk, and of course with leading EU biotech investors from the Broadreach Global network, including Cedric Bisson of Teralys Capital, Bruno Montanari of Seroba., Raúl Martín-Ruiz of Ysios Capital, Manuel Lopez-Figueroa of Bay City Capital LLC, as well as top funds which contributed anonymously, angel investors Mark Treherne and Till Erdmann, and Andrea Soto Padilla. Special thanks to Antoine Mialhe and Alexander Natz
-
-
Shorla Oncology, Seroba. portfolio company, has just achieved another great milestone with the FDA Approval of IMKELDI, an oral solution to treat certain forms of leukemia and other cancers. For the US-Irish specialty pharmaceutical company, this marks the fourth FDA approval for oncology treatments. Congratulations to the Shorla team! #Formulation #Innovation #Oncology #VCbacked #SerobaFunding
PRESS RELEASE: Shorla Oncology Announces FDA Approval of IMKELDI (imatinib) Oral Solution, an Oral Liquid for the Treatment of Certain Forms of Leukemia and Other Cancers https://lnkd.in/egwN63Cv
-
Another great Office Hours session at PorterShed with additional support from AIB. Thank you to everyone that met with Jennifer McMahon and Sophie Hughes, PhD, and shared their stories. We hope it was a valuable and informative session for all business creators and entrepreneurs.
🤝 A huge thank you to Sophie Hughes, PhD and Jennifer McMahon from Seroba. for joining us for today's guest Office Hours session. 🔬They provided valuable guidance and support for our members and the wider PorterShed community. If you’re operating in the Life Sciences space and seeking the right investment partner or advice on where to start, reach out to the team at Seroba. 🙌 It was great to have Lisa Cooley and Niall Canny from the AIB banking team available for additional support! #thisisgalway #portershed #galwaycity
-
-
Great news for Quanta Dialysis Technologies, a Seroba. portfolio company. After their recent FDA clearance, they have now closed on an oversubscribed Series E funding, raising over $60m in capital. With this, they will expand its commercial presence in the US and continue to invest in cutting-edge innovation within the sector. For more information: https://lnkd.in/eBm6Kyn4
Quanta is thrilled to announce the successful closing of its oversubscribed Series E funding round, led by Novo Holdings, Glenview Capital and b2venture. This latest capital injection will help Quanta expand its commercial presence in the US, while ensuring customers, industry partners and patients can continue to rely on the company's robust financial foundations. See our official press release here: https://lnkd.in/gFh7GEms #Quanta #QuantaDT #kidneycare #nephrology #healthcareinnovation
-
-
Another great opportunity in the portfolio with Loci Orthopaedics! #SerobaVC #Regulatory #Medtech
-
Seroba portfolio company ShiraTronics, Inc. is hiring a Vice President of Finance in Ireland! Head over to the #ShiraTronics's page to check out the job post and learn more about this exciting opportunity and help to transform the lives of patients with chronic migraine. #Medtech #Finance #NewJob #Hiring
-
-
Alan O'Connell and Daniel O'Mahony, partners at Seroba., were delighted to attend the Goodbody celebration of 150 years serving its clients at the beautiful Examination Hall in Trinity College Dublin last night. Bryan Dobson hosted the night with a discussion on how the Irish economy has transformed over recent decades and how we can we continue to build ongoing growth and prosperity with Colin Hunt, CEO, AIB and Frank O'Connor, CEO of National Treasury Management Agency followed by an insightful discussion on the potential transformative impact of AI on the economy. Thank you to Martin Tormey who walked us through the story of how Robert Goodbody founded the firm in 1874 and how it has grown and thrived over the intervening years and to the Goodbody team for hosting a great evening and congratulations on your 150th! Alan Mahon Cathy Bryce Finlay McFadyen Richard Morton Don Harrington Simon Howley
-